Private Sector's Critical Role in Biomedical Innovation
Private Sector's Critical Role in Biomedical Innovation
![BIO Toolkit: Private Sector's Critical Role in Biomedical Innovation](/sites/default/files/2024-03/bio-analysis-nih-grants-page1.jpg)
Private Sector's Critical Role in Biomedical Innovation
There is a misguided perception that NIH funding, not private market investment, is largely responsible for the creation and approval of new therapies. A new study by Vital Transformation¹ tests that hypothesis by tracking more than 20,000 patents linked to NIH grant over a 20 year period, identifying those associated with clinical trials and approved medicines, and quantifying the public and private investments made for those investigational and approved medicines.
![Private Sector's Critical Role in Biomedical Innovation](/sites/default/files/2024-03/bio-analysis-nih-grants-page2.jpg)
Private Sector's Critical Role in Biomedical Innovation
There is a misguided perception that NIH funding, not private market investment, is largely responsible for the creation and approval of new therapies. A new study by Vital Transformation¹ tests that hypothesis by tracking more than 20,000 patents linked to NIH grant over a 20 year period, identifying those associated with clinical trials and approved medicines, and quantifying the public and private investments made for those investigational and approved medicines.